Literature DB >> 23157245

Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report.

N Yokoyama, M Niino, T Takahashi, M Matsushima, Y Maruo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23157245     DOI: 10.1111/j.1468-1331.2012.03880.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  6 in total

Review 1.  Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Ann N Y Acad Sci       Date:  2015-06-10       Impact factor: 5.691

Review 2.  The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Yong Guo; Bogdan F Gh Popescu; Kazuo Fujihara; Yasuto Itoyama; Tatsuro Misu
Journal:  Brain Pathol       Date:  2014-01       Impact factor: 6.508

3.  Muscle damage in patients with neuromyelitis optica spectrum disorder.

Authors:  Hong-Xi Chen; Qin Zhang; Zhi-Yun Lian; Ju Liu; Zi-Yan Shi; Xiao-Hui Miao; Hui-Ru Feng; Qin Du; Jing-Lu Xie; Shao-Li Yao; Hong-Yu Zhou
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-09-13

Review 4.  Müller cells and retinal axons can be primary targets in experimental neuromyelitis optica spectrum disorder.

Authors:  Bleranda Zeka; Hans Lassmann; Monika Bradl
Journal:  Clin Exp Neuroimmunol       Date:  2017-01-11

5.  Multisystem involvement in neuromyelitis optica.

Authors:  Megan M Langille; Jay Desai
Journal:  Ann Indian Acad Neurol       Date:  2015-09       Impact factor: 1.383

Review 6.  Experimental models of neuromyelitis optica.

Authors:  Monika Bradl; Hans Lassmann
Journal:  Brain Pathol       Date:  2014-01       Impact factor: 6.508

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.